Figure 7.
Comparison between the predicted binding mode and in vitro FXa inhibition for (A) compound 5 (NSC635393) and (B) Rivaroxaban.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.